Assessment of a next generation sequencing gene panel strategy in 133 patients with negative thrombophilia screening
Journal of Thrombosis and Haemostasis · 2025
DOI: 10.1016/j.jtha.2024.12.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Pierre Suchon und 16 weiteren Autor:innen. Beteiligte Einrichtung: C2VN, INSERM, INRAE, Aix Marseille University, Marseille, France; Laboratory of Haematology, La Timone Hospital, Marseille, France. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Venous Thromboembolism, Thrombophilia, Genetic Testing. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Although heritability of venous thromboembolism (VTE) is high, the thrombophilia screening appears to be positive only in a minority of VTE patients. Adding rare variants screening to identify VTE missing heritability still requires further assessment. OBJECTIVES: We report the results of a panel strategy after 3 years of application. METHODS: We performed the sequencing of 28 genes related to coagulation cascade and/or VTE using high-throughput sequencing in133 unrelated patients with a personal history of VTE and negative thrombophilia screening. Only variants with minor allele frequency
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- C2VN, INSERM, INRAE, Aix Marseille University, Marseille, France; Laboratory of Haematology, La Timone Hospital, Marseille, France.
- Bordeaux Population Health Research Center, INSERM UMR 1219, University of Bordeaux, Bordeaux, France; INSERM, Biology of Cardiovascular Diseases, University of Bordeaux, Pessac, France.
- Laboratory of Haematology, La Timone Hospital, Marseille, France.
- Department of Pediatric Oncology and Hematology, University of Montpellier, Montpellier University Hospital, Montpellier, France; Resources and Competence Center for Constitutional Bleeding Disorders, University of Mont…
- Department of Biological Hematology, Resources and Competence Center for Constitutional Bleeding Disorders, University of Montpellier, Montpellier, France.
- Hematology and Transfusion Department, Institut National de la Santé et de la Recherche Médicale, Centre Hospitalier Universitaire de Lille, Institut Pasteur de Lille, Université de Lille, U1011-European Genomic Institu…
Zitieren
APA
Suchon, P., Soukarieh, O., Bernard, C., Mariotti, A., Ernest, V., Barthet, M. C., Saut, N., Theron, A., Biron-Andréani, C., Daniel, M. Y., Catella, J., Rohrlich, P. S., Blanc-Jouvan, F., Le Cam Duchez, V., Dari, L., Trégouët, D. A., & Morange, P. E. (2025). Assessment of a next generation sequencing gene panel strategy in 133 patients with negative thrombophilia screening. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.12.006
Vancouver
Suchon P, Soukarieh O, Bernard C, Mariotti A, Ernest V, Barthet MC, et al. Assessment of a next generation sequencing gene panel strategy in 133 patients with negative thrombophilia screening. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2024.12.006
BibTeX
@article{Suchon2025,
author = {Suchon, Pierre and Soukarieh, Omar and Bernard, Clara and Mariotti, Antoine and Ernest, Vincent and Barthet, Marie-Christine and Saut, Noémie and Theron, Alexandre and Biron-Andréani, Christine and Daniel, Mélanie Y and Catella, Judith and Rohrlich, Pierre-Simon and Blanc-Jouvan, Florence and Le Cam Duchez, Véronique and Dari, Loubna and Trégouët, David-Alexandre and Morange, Pierre-Emmanuel},
title = {Assessment of a next generation sequencing gene panel strategy in 133 patients with negative thrombophilia screening},
journal = {Journal of Thrombosis and Haemostasis},
year = {2025},
doi = {10.1016/j.jtha.2024.12.006}
}
EUVIMED